Thor Medical ASA (TRMED) - Total Liabilities
Based on the latest financial reports, Thor Medical ASA (TRMED) has total liabilities worth Nkr314.10 Million NOK (≈ $33.05 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Thor Medical ASA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Thor Medical ASA - Total Liabilities Trend (2019–2025)
This chart illustrates how Thor Medical ASA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Thor Medical ASA (TRMED) total assets.
Thor Medical ASA Competitors by Total Liabilities
The table below lists competitors of Thor Medical ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
High Tide Inc
NASDAQ:HITI
|
USA | $244.82 Million |
|
Centratama Telekomunikasi Ind
JK:CENT
|
Indonesia | Rp24.58 Trillion |
|
Winton Land Ltd
AU:WTN
|
Australia | AU$196.54 Million |
|
GTM Holdings Corp
TW:1437
|
Taiwan | NT$5.53 Billion |
|
Critical Holdings Berhad
KLSE:0291
|
Malaysia | RM75.50 Million |
|
Anhui Provincial Architectural Design and Research Institute Co.Ltd.
SHE:301167
|
China | CN¥369.32 Million |
|
Naturgy BAN SA
BA:GBAN
|
Argentina | AR$381.10 Billion |
|
Coca Cola HBC AG
LSE:CCH
|
UK | GBX10.78 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Thor Medical ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Thor Medical ASA balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thor Medical ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thor Medical ASA (2019–2025)
The table below shows the annual total liabilities of Thor Medical ASA from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr252.64 Million ≈ $26.58 Million |
+226.83% |
| 2024-12-31 | Nkr77.30 Million ≈ $8.13 Million |
+31.22% |
| 2023-12-31 | Nkr58.91 Million ≈ $6.20 Million |
+28.62% |
| 2022-12-31 | Nkr45.80 Million ≈ $4.82 Million |
-70.67% |
| 2021-12-31 | Nkr156.16 Million ≈ $16.43 Million |
+14.87% |
| 2020-12-31 | Nkr135.94 Million ≈ $14.31 Million |
+2874.01% |
| 2019-12-31 | Nkr4.57 Million ≈ $481.00K |
-- |
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.